Our pipeline
We've played an instrumental role in bringing 13 new cancer drugs to market. Now, we're continuing to fast-track scientific breakthroughs into patient benefit through our pioneering research.
Our robust and sustainable pipeline spans early stage discovery through to clinical trials.
There's more on the horizon
Learn more about our pipeline, partnering opportunities and more to translate discoveries into patient benefit.